US FDA 510(k): Best Practices for 510(k) Preparation and Submission

This webinar will discuss best practices for premarket notification [510(k)] preparation and submission compliant with FDA's eCopy and Refuse to Accept (RTA) Policy requirements.

Why Should You Attend:

Although it is believed there are various factors contributing to timing of 510(k) clearances, it is imperative more than ever from our industry perspectives that the medical device manufacturers understand recent changes (hurdles and new requirements) and be able to prepare a 510(k) in a sufficiently adequate way to expedite the review process and successful clearance without delays, saving an enormous amount of time, energy, and resources.

In this webinar, speaker will discuss how to put together a compelling 510(k) package. In particular, the speaker will share what he has observed and learned from his own experience and also based on his analysis of 510(k)s recently cleared.

This 60-minute webinar will provide great opportunity to implement your good practices for a 510(k) preparation and submission while meeting eCopy and RTA policy requirements necessary for obtaining 510(k) clearances.

Areas Covered in the Webinar:

• Statute(s) and regulations governing 510(k)s
• Definitions and medical device classification including IVD devices
• Intended use, indications, and predicates
• eCopy program
• Refuse to accept (RTA) policy
• Standards - benefits
• Who/when is required to submit a 510(k)
• Regulatory requirements: performance testing and/or clinical data
• 510(k) content and format
• How to increase 510(k) submission quality for a product.
• Responding to FDA’s request of additional information.
• Resolving different opinions between the submitter and FDA reviewer(s)
• Good practices: Dos and Don’ts including de novo process
• Conclusion

Who Will Benefit:

• Regulatory affairs (associates, specialists, managers, directors or VPs)
• Quality professionals (associates, specialists, managers, directors or VPs)
• R&D (engineers, scientists, managers, directors or VPs)
• Complaint and risk management personnel
• Consultants
• Contractors/subcontractors
• CEOs
• VPs
• Clinical affairs (associates, specialists, managers, directors or VPs)